NF
IDXX icon

Nvest Financial’s Idexx Laboratories IDXX Stock Holding History

Nvest Financial’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,853
Closed -$766K – 102
2024
Q4 		$766K Sell
1,853
-388
-17% -$170K 0.39% 64
2024
Q3 		$1.13M Buy
2,241
+109
+5% +$53K 0.65% 45
2024
Q2 		$1.04M Buy
2,132
+250
+13% +$126K 0.64% 44
2024
Q1 		$1.02M Buy
1,882
+275
+17% +$150K 0.68% 41
2023
Q4 		$892K Buy
1,607
+523
+48% +$246K 0.7% 36
2023
Q3 		$474K Buy
1,084
+301
+38% +$150K 0.44% 43
2023
Q2 		$393K Buy
783
+315
+67% +$151K 0.34% 46
2023
Q1 		$234K Buy
+468
New +$224K 0.24% 59
2022
Q2 		– Sell
-404
Closed -$221K – 60
2022
Q1 		$221K Buy
+404
New +$213K 0.18% 69

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Nvest Financial's IDXX Position: Q1 2025 in Review

Nvest Financial sold out of Idexx Laboratories (IDXX) in Q1 2025, closing a stake of 1,853 shares — an estimated $766K sold.

Nvest Financial first reported a position in IDXX in Q1 2022 and held it in 9 quarters. The position peaked at $1.13M in Q3 2024. 1,142 funds tracked by Wall St. Rank hold IDXX as of Q1 2025.

  • Nvest Financial reported no remaining Idexx Laboratories position as of Q1 2025 after selling out during the quarter.
  • Nvest Financial sold 1,853 Idexx Laboratories shares in Q1 2025, an estimated $766K.
  • Nvest Financial first reported a position in Idexx Laboratories in Q1 2022 and held it in 9 quarters.
  • Nvest Financial's Idexx Laboratories position peaked at $1.13M in Q3 2024.
  • 1,142 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2025.

Based on Nvest Financial's 13F filing for Q1 2025, filed 23 Apr 2025.